allylamine has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Henney, JE | 1 |
Chen, GA; Lorang, D; Nguyen, DM; Schrump, DS; Stewart, JH; Tabibi, E | 1 |
2 other study(ies) available for allylamine and Lung Neoplasms
Article | Year |
---|---|
From the Food and Drug Administration.
Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Hydrogels; Hypercholesterolemia; Lung Neoplasms; Surgical Equipment; United States; United States Food and Drug Administration | 2000 |
Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis.
Topics: Allylamine; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoquinones; Benzothiazoles; Carcinoma, Non-Small-Cell Lung; Cell Survival; Drug Synergism; Drug Therapy, Combination; Endothelial Growth Factors; Humans; Lactams, Macrocyclic; Lung Neoplasms; Lymphokines; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Paclitaxel; Quinones; Tumor Cells, Cultured; Tyrphostins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |